CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Zhuzhou Qianjin Pharmaceutical Co., Ltd. Company Snapshot
Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other companies in this sector in China: Hunan Jingfeng Pharmaceutical Co Ltd (2015 sales of 2.46 billion Chinese Renmimbi [US$354.39 million] of which 98% was Manufacturing), Zhejiang Hisoar Pharmaceutical Co. Ltd (2.46 billion Chinese Renmimbi [US$355.21 million] of which 50% was Pharmatheutical Industry), and Zhejiang Xianju Pharmaceutical Co Limited (2.48 billion Chinese Renmimbi [US$357.34 million] of which 100% was Medicine).

Sales Analysis. During the year ended December of 2015, sales at Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 2.45 billion Chinese Renmimbi (US$352.45 million). This is an increase of 11.5% versus 2014, when the company's sales were 2.19 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd. (and since 2010, sales have increased a total of 150%). Sales of Other saw an increase that was more than double the company's growth rate: sales were up 73.6% in 2015, from 92.34 million Chinese Renmimbi to 160.34 million Chinese Renmimbi. Zhuzhou Qianjin Pharmaceutical Co., Ltd. also saw significant increases in sales in Medicine Retail Sales and Wholesales (up 15.0% to 1.03 billion Chinese Renmimbi) .
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
  Stock Performance Chart for Zhuzhou Qianjin Pharmaceutical Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 15.90
(Figures in Chinese Renmimbi)
1 Week 3.5%   13 Weeks 3.0%  
4 Weeks -4.9%   52 Weeks 14.7%  
 
Zhuzhou Qianjin Pharmaceutical Co., Ltd. Key Data:
  Ticker: 600479 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 2,445,363,236
(Year Ending Jan 2016).
Employees: 4,296
  Currency: Chinese Renmimbi Market Cap: 5,545,219,303
  Fiscal Yr Ends: December Shares Outstanding: 348,755,931
  Share Type: A Gu Closely Held Shares: 121,234,098
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.